Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

Rabbit Anti-Human PAX5 monoclonal antibody, clone TQ45


View Antibody details

Rabbit Anti-Human PAX6 Monoclonal Antibody, Clone S12-2H9


View Antibody details

Rabbit Anti-Human PAX8 monoclonal antibody, clone KK19-99


View Antibody details

Rabbit Anti-Human PCAF monoclonal antibody, clone F.208.0


View Antibody details

Rabbit Anti-Human PCBP1 Monoclonal Antibody, Clone S18-3O6


View Antibody details

Rabbit Anti-Human PCBP2 Monoclonal Antibody, Clone S12-3G6


View Antibody details

Rabbit Anti-Human PDCD1 monoclonal antibody, clone TK12-02


View Antibody details

Rabbit Anti-Human PDCD4 monoclonal antibody, clone 2I26M7


View Antibody details

Rabbit Anti-Human PDCD6IP Monoclonal Antibody, Clone S14-9D3


View Antibody details

Rabbit Anti-Human PDGFRA/PDGFRB (phospho Tyr849, Tyr857) monoclonal antibody, clone U.675.9


View Antibody details